Recent Posts by Sales Firalis

FIRALIS S.A. appoints Alain FOURNELLE as Chief Financial Officer

    Huningue, France, July 31st, 2019 - Firalis S.A (“Firalis”), a developer of biomarker-based products and provider of biomarker services announces the appointment of Alain Fournelle as new Chief Financial Officer. Alain has three decades of financial expertise in various fields of financial recovery, due diligence and mergers & acquisitions as consultant at E&Y…
Read more

Amoneta Diagnostics has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF)

      In support of the MemoryLINC project “Validation of a Rapid Non-Invasive Diagnostic Test to Predict Mild-Cognitive Impairment and Early Alzheimer's Disease”, Amoneta Diagnostics S.A.S. has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF) Diagnostics Accelerator Huningue, May 31st, 2019 – Amoneta Diagnostics SAS, an affiliate…
Read more

FIRALIS : The Korean & Japanese market

FIRALIS, a high-tech company specialized in precision medicine and biotechnology. For more than 10 years, this biotech has been developing and commercializing diagnostic products that improve the management of disease in patients and therapeutic decisions, through the discovery and development of biomarkers , with a direct impact for better results incluiding comfort in patients and…
Read more

Recent Comments by Sales Firalis

No comments by Sales Firalis yet.